179 related articles for article (PubMed ID: 32503460)
1. Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.
Klein Nulent TJW; Valstar MH; Smit LA; Smeele LE; Zuithoff NPA; de Keizer B; de Bree R; van Es RJJ; Willems SM
BMC Cancer; 2020 Jun; 20(1):519. PubMed ID: 32503460
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.
Klein Nulent TJW; van Es RJJ; Krijger GC; de Bree R; Willems SM; de Keizer B
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1614-1621. PubMed ID: 28593386
[TBL] [Abstract][Full Text] [Related]
3. High CXCR4 expression in adenoid cystic carcinoma of the head and neck is associated with increased risk of locoregional recurrence.
Klein Nulent TJW; van Es RJJ; Valstar MH; Smeele LE; Smit LA; Klein Gunnewiek R; Zuithoff NPA; de Keizer B; de Bree R; Willems SM
J Clin Pathol; 2020 Aug; 73(8):476-482. PubMed ID: 31948995
[TBL] [Abstract][Full Text] [Related]
4.
van Boxtel W; Lütje S; van Engen-van Grunsven ICH; Verhaegh GW; Schalken JA; Jonker MA; Nagarajah J; Gotthardt M; van Herpen CML
Theranostics; 2020; 10(5):2273-2283. PubMed ID: 32089741
[No Abstract] [Full Text] [Related]
5. Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery.
Jeong IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 May; 146(5):1343-1350. PubMed ID: 32144535
[TBL] [Abstract][Full Text] [Related]
6. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: a single institutional experience at a tertiary care center.
Marcinow A; Ozer E; Teknos T; Wei L; Hurtuk A; Old M; Agrawal A; Carrau R; Iwenofu OH
Head Neck; 2014 Dec; 36(12):1705-11. PubMed ID: 24166847
[TBL] [Abstract][Full Text] [Related]
8. The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.
Kawakita D; Murase T; Ueda K; Kano S; Tada Y; Tsukahara K; Okami K; Onitsuka T; Fujimoto Y; Matoba T; Sakurai K; Nagao T; Hanai N; Kawata R; Hato N; Nibu KI; Urano M; Taguchi KI; Nakaguro M; Kusafuka K; Yamamoto H; Nagao T; Inagaki H
Int J Clin Oncol; 2020 Oct; 25(10):1774-1785. PubMed ID: 32613404
[TBL] [Abstract][Full Text] [Related]
9. Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
Lombardi D; Tomasoni M; Lorini L; Gurizzan C; Tomasini D; Ardighieri L; Battocchio S; Bozzola A; Mattavelli D; Paderno A; Zamparini M; Farina D; Ravanelli M; Maroldi R; Maddalo M; Magrini S; Berruti A; Deganello A; Nicolai P; Bossi P; Piazza C
Oral Oncol; 2022 Mar; 126():105764. PubMed ID: 35158286
[TBL] [Abstract][Full Text] [Related]
10. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.
van Weert S; Reinhard R; Bloemena E; Buter J; Witte BI; Vergeer MR; Leemans CR
Head Neck; 2017 Mar; 39(3):456-463. PubMed ID: 27775851
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors and Survival in Adenoid Cystic Carcinoma of the Head and Neck: A Retrospective Clinical and Histopathological Analysis of Patients Seen at a Cancer Center.
de Morais EF; da Silva LP; Moreira DGL; Mafra RP; Rolim LSA; de Moura Santos E; de Souza LB; de Almeida Freitas R
Head Neck Pathol; 2021 Jun; 15(2):416-424. PubMed ID: 32779101
[TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.
Oplatek A; Ozer E; Agrawal A; Bapna S; Schuller DE
Laryngoscope; 2010 Jan; 120(1):65-70. PubMed ID: 19877226
[TBL] [Abstract][Full Text] [Related]
13. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Fendler WP; Weber M; Iravani A; Hofman MS; Calais J; Czernin J; Ilhan H; Saad F; Small EJ; Smith MR; Perez PM; Hope TA; Rauscher I; Londhe A; Lopez-Gitlitz A; Cheng S; Maurer T; Herrmann K; Eiber M; Hadaschik B
Clin Cancer Res; 2019 Dec; 25(24):7448-7454. PubMed ID: 31511295
[TBL] [Abstract][Full Text] [Related]
14. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.
Meyers M; Granger B; Herman P; Janot F; Garrel R; Fakhry N; Poissonnet G; Baujat B;
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):13-7. PubMed ID: 26493113
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
16. Utility of
Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
[TBL] [Abstract][Full Text] [Related]
17. [Adenoid cystic carcinoma of the head and neck: a review of 30 cases].
Raux-Rakotomalala F; Houliat T; Martel J; Stoll D; Bébéar JP; Darrouzet V
Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):235-41. PubMed ID: 15038566
[TBL] [Abstract][Full Text] [Related]
18. Dominant cell type analysis predicts head and neck adenoid cystic carcinoma outcomes.
Xuan L; Yuan J; Zhang H; Zhang Y; Liu H
Ann Diagn Pathol; 2022 Feb; 56():151867. PubMed ID: 34826781
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with
Ferraro DA; Rüschoff JH; Muehlematter UJ; Kranzbühler B; Müller J; Messerli M; Husmann L; Hermanns T; Eberli D; Rupp NJ; Burger IA
Theranostics; 2020; 10(14):6082-6094. PubMed ID: 32483440
[TBL] [Abstract][Full Text] [Related]
20. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
Xiang M; Ma TM; Savjani R; Pollom EL; Karnes RJ; Grogan T; Wong JK; Motterle G; Tosoian JJ; Trock BJ; Klein EA; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Levin-Epstein R; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Huland H; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Alam R; Schwen Z; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Chong N; Kupelian PA; Rettig MB; Zaorsky NG; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Tilki D; Czernin J; Gafita A; Romero T; Calais J; Kishan AU
JAMA Netw Open; 2021 Dec; 4(12):e2138550. PubMed ID: 34902034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
